New blood test aims to catch sepsis before It's too late
NCT ID NCT05922371
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study looked at whether a new blood test (NuQ H3.1) can help doctors diagnose sepsis faster in adults admitted to intensive care with signs of infection. Researchers compared 34 sepsis patients to a group of surgical patients without infection. The goal was to see if the test could track disease severity and help predict outcomes, potentially leading to quicker treatment.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for SEPSIS are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Guy's & St Thomas' NHS Foundation Trust
London, London, SE1 9RT, United Kingdom
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can we optimize antibiotic dosing for children with sepsis?
- Could starting feeds sooner shield preterm babies from infection?
- Can brain waves predict thinking problems after sepsis?
- Can tailored nutrition boost recovery in the ICU?
- Blood markers may foretell brain fog after sepsis
- A hidden clue in the fingertips: could a pulse oximeter reading forecast sepsis outcomes?